Jan 24 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd
* Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Henan Food and Drug Administration
* Certificate issued to edaravone manufactured by the unit and the valid period is until Jan. 7, 2023
Source text in Chinese: goo.gl/2sR7k1
Further company coverage: (Beijing Headline News)
 